Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Jindrich Cinatl and Sandra Ciesek.
Connection Strength

2.858
  1. Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings. Med Microbiol Immunol. 2021 Aug; 210(4):235-244.
    View in: PubMed
    Score: 0.238
  2. Infectivity of deceased COVID-19 patients. Int J Legal Med. 2021 Sep; 135(5):2055-2060.
    View in: PubMed
    Score: 0.233
  3. A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection. Sci Data. 2021 02 26; 8(1):70.
    View in: PubMed
    Score: 0.233
  4. Differentially conserved amino acid positions may reflect differences in SARS-CoV-2 and SARS-CoV behaviour. Bioinformatics. 2021 Feb 09.
    View in: PubMed
    Score: 0.232
  5. Aprotinin Inhibits SARS-CoV-2 Replication. Cells. 2020 10 30; 9(11).
    View in: PubMed
    Score: 0.228
  6. Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells. Stem Cell Reports. 2021 03 09; 16(3):419-427.
    View in: PubMed
    Score: 0.226
  7. Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication. Mol Cell. 2020 10 01; 80(1):164-174.e4.
    View in: PubMed
    Score: 0.224
  8. COVID-19-Related Coagulopathy-Is Transferrin a Missing Link? Diagnostics (Basel). 2020 Jul 30; 10(8).
    View in: PubMed
    Score: 0.224
  9. Lack of antiviral activity of darunavir against SARS-CoV-2. Int J Infect Dis. 2020 Aug; 97:7-10.
    View in: PubMed
    Score: 0.221
  10. Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China. N Engl J Med. 2020 03 26; 382(13):1278-1280.
    View in: PubMed
    Score: 0.217
  11. Characterization of ACE Inhibitors and AT1R Antagonists with Regard to Their Effect on ACE2 Expression and Infection with SARS-CoV-2 Using a Caco-2 Cell Model. Life (Basel). 2021 Aug 10; 11(8).
    View in: PubMed
    Score: 0.060
  12. Detection and infectivity of SARS-CoV-2 in exhumated corpses. Int J Legal Med. 2021 Nov; 135(6):2531-2536.
    View in: PubMed
    Score: 0.060
  13. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants. Basic Res Cardiol. 2021 07 05; 116(1):42.
    View in: PubMed
    Score: 0.060
  14. In vitro activity of itraconazole against SARS-CoV-2. J Med Virol. 2021 Jul; 93(7):4454-4460.
    View in: PubMed
    Score: 0.060
  15. Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection. J Biol Chem. 2021 08; 297(2):100925.
    View in: PubMed
    Score: 0.060
  16. A method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization. Sci Rep. 2021 05 26; 11(1):11049.
    View in: PubMed
    Score: 0.059
  17. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes. Cardiovasc Res. 2020 12 01; 116(14):2207-2215.
    View in: PubMed
    Score: 0.057
  18. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature. 2020 11; 587(7835):657-662.
    View in: PubMed
    Score: 0.056
  19. Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs. Int J Mol Sci. 2020 Jun 20; 21(12).
    View in: PubMed
    Score: 0.056
  20. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature. 2020 07; 583(7816):469-472.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.